ST PHARM

ST Pharm Co., Ltd. is a South Korean contract development and manufacturing organisation (CDMO) specialising in active pharmaceutical ingredients (APIs) and nucleic acid therapeutics.

Established in 1983, ST Pharm has over 30 years of experience in delivering custom manufacturing services for APIs and intermediates, adhering to current Good Manufacturing Practices (cGMP). The company has built a reputation for reliability and expertise in process development and scale-up optimisation, serving numerous global pharmaceutical companies and biotech firms.

Key Products and Services:

• Small Molecule APIs: Custom manufacturing services for small molecule active pharmaceutical ingredients.
• Oligonucleotide Therapeutics: Production of oligonucleotides for gene therapy applications.
• mRNA Therapeutics: Development and manufacturing services for mRNA-based drugs.
• Contract Research Organisation (CRO) Services: Through its subsidiary, AnaPath Research & Service, ST Pharm offers comprehensive research services.
• Virtual and Global R&D: Engaging in both virtual and global research and development initiatives to advance pharmaceutical innovation.

With a commitment to innovation, transition, trust, and collective growth, ST Pharm positions itself as an innovative company dedicated to saving lives. The company operates multiple cGMP manufacturing facilities and maintains a strong global presence, continually expanding its capabilities in the pharmaceutical industry